论文部分内容阅读
礼来制药公司董事长、总裁兼首席执行官John Lechieiter分享在中国战略、创新以及社会责任等问题上的见解。连续多年的飞速经济发展一改中国曾经的“东亚病夫”形象,但也带来了不幸的副作用,例如“富贵病”(糖尿病、乳腺癌和心血管疾病等)的发病率猛增。由此产生的药物需求,加上人们日益提高的收入水平,使得中国的药品市场以每
John Lechieiter, Chairman, President and Chief Executive Officer, Lilly Pharmaceutical Company, shares insights on China’s strategy, innovation and social responsibility issues. The rapid economic development that has been going on for many years has changed the former image of China’s “sick man of East Asia”, but it has also brought unfortunate side effects such as a sharp increase in the incidence of “affluence” (diabetes, breast cancer and cardiovascular diseases) . The resulting drug demand, coupled with increasing income levels, make China’s drug market every